Aytu BioPharma Inc. (AYTU)
1.66
0.00 (0.00%)
At close: Jan 14, 2025, 3:58 PM
1.64
-1.20%
After-hours Jan 14, 2025, 03:59 PM EST
undefined% (undefined)
| Bid | 1.62 |
| Market Cap | 10.21M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.7 |
| PE Ratio (ttm) | -0.98 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 3 |
| Volume | 9,223 |
| Avg. Volume (20D) | 35,745 |
| Open | 1.63 |
| Previous Close | 1.66 |
| Day's Range | 1.62 - 1.67 |
| 52-Week Range | 1.30 - 3.45 |
| Beta | undefined |
About AYTU
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the...
Sector Healthcare
IPO Date Sep 25, 2008
Employees 102
Stock Exchange NASDAQ
Ticker Symbol AYTU
Website https://aytubio.com
Analyst Forecast
According to 1 analyst ratings, the average rating for AYTU stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
2 months ago ·
Source
-11.43%
Aytu BioPharma shares are trading lower. The compa...
Unlock content with
Pro Subscription
3 months ago ·
Source
-17.19%
Aytu BioPharma shares are trading lower after the company reported worse-than-expected Q4 financial results.
